164 related articles for article (PubMed ID: 14980642)
21. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats.
Sakurai H; Sano H; Takino T; Yasui H
J Inorg Biochem; 2000 May; 80(1-2):99-105. PubMed ID: 10885469
[TBL] [Abstract][Full Text] [Related]
22. Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats.
Edel AL; Kopilas M; Clark TA; Aguilar F; Ganguly PK; Heyliger CE; Pierce GN
Metabolism; 2006 Feb; 55(2):263-70. PubMed ID: 16423636
[TBL] [Abstract][Full Text] [Related]
23. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.
Saatchi K; Thompson KH; Patrick BO; Pink M; Yuen VG; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2689-97. PubMed ID: 15819554
[TBL] [Abstract][Full Text] [Related]
24. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on non-diabetic and streptozotocin-diabetic rats.
Gao LH; Liu WP; Wang BL; Li L; Xie MJ; Li YR; Chen ZH; Chen XZ
Clin Chim Acta; 2006 Jun; 368(1-2):173-8. PubMed ID: 16487949
[TBL] [Abstract][Full Text] [Related]
25. Antidiabetic activity of the orally effective vanadyl-poly (gamma-glutamic acid) complex in streptozotocin(STZ)-induced type 1 diabetic mice.
Karmaker S; Saha TK; Sakurai H
J Biomater Appl; 2008 Mar; 22(5):449-64. PubMed ID: 17494957
[TBL] [Abstract][Full Text] [Related]
26. A new salicylic acid-derivatized kojic acid vanadyl complex: synthesis, characterization and anti-diabetic therapeutic potential.
Wei Y; Zhang C; Zhao P; Yang X; Wang K
J Inorg Biochem; 2011 Aug; 105(8):1081-5. PubMed ID: 21726771
[TBL] [Abstract][Full Text] [Related]
27. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
[TBL] [Abstract][Full Text] [Related]
28. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
29. Effective control of blood glucose status and toxicity in streptozotocin-induced diabetic rats by orally administration of vanadate in an herbal decoction.
Zhang L; Zhang Y; Xia Q; Zhao XM; Cai HX; Li DW; Yang XD; Wang K; Xia ZL
Food Chem Toxicol; 2008 Sep; 46(9):2996-3002. PubMed ID: 18601969
[TBL] [Abstract][Full Text] [Related]
30. Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes.
Kawabe K; Yoshikawa Y; Adachi Y; Sakurai H
Life Sci; 2006 May; 78(24):2860-6. PubMed ID: 16337244
[TBL] [Abstract][Full Text] [Related]
31. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
Fugono J; Yasui H; Sakurai H
J Pharm Pharmacol; 2005 May; 57(5):665-9. PubMed ID: 15901357
[TBL] [Abstract][Full Text] [Related]
32. The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes?
Brichard SM; Lederer J; Henquin JC
Diabete Metab; 1991; 17(5):435-40. PubMed ID: 1752343
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic study on gastrointestinal absorption of insulinomimetic vanadyl complexes in rats by ESR spectroscopy.
Fugono J; Yasui H; Sakurai H
J Pharm Pharmacol; 2001 Sep; 53(9):1247-55. PubMed ID: 11578107
[TBL] [Abstract][Full Text] [Related]
34. Anti-diabetic effects of cesium aqua (N,N'-ethylene(salicylideneiminato)-5-sulfonato) oxovanadium (IV) dihydrate in streptozotocin-induced diabetic rats.
Li M; Wei D; Ding W; Baruah B; Crans DC
Biol Trace Elem Res; 2008 Mar; 121(3):226-32. PubMed ID: 17968514
[TBL] [Abstract][Full Text] [Related]
35. Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats.
Ramachandran B; Kandaswamy M; Narayanan V; Subramanian S
Diabetes Obes Metab; 2003 Nov; 5(6):455-61. PubMed ID: 14617232
[TBL] [Abstract][Full Text] [Related]
36. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Bolkent S; Bolkent S; Yanardag R; Tunali S
Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, spectroscopic, structural and thermal characterizations of vanadyl(IV) adenine complex prospective as antidiabetic drug agent.
El-Megharbel SM; Hamza RZ; Refat MS
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():850-64. PubMed ID: 25150436
[TBL] [Abstract][Full Text] [Related]
39. Effect of Vanadyl Rosiglitazone, a New Insulin-Mimetic Vanadium Complexes, on Glucose Homeostasis of Diabetic Mice.
Jiang P; Dong Z; Ma B; Ni Z; Duan H; Li X; Wang B; Ma X; Wei Q; Ji X; Li M
Appl Biochem Biotechnol; 2016 Nov; 180(5):841-851. PubMed ID: 27240663
[TBL] [Abstract][Full Text] [Related]
40. Effects of insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex on diabetic rat model.
Hu R; He C; Liu J; Wu Y; Li J; Feng Z; Huang J; Xi XG; Wu Z
J Pharm Sci; 2010 Jul; 99(7):3041-7. PubMed ID: 20120019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
